ALERT: This system is being upgraded on Tuesday December 12. It will not be available for use for several hours that day while the upgrade is in progress. Deposits to DukeSpace will be disabled on Monday December 11, so no new items are to be added to the repository while the upgrade is in progress. Everything should be back to normal by the end of day, December 12.

Browsing by Author "Gadalla, Shahinaz M"

Now showing items 1-3 of 3

    • Outcomes of allogeneic hematopoietic cell transplantation in patients with dyskeratosis congenita. 

      Gadalla, Shahinaz M; Sales-Bonfim, Carmem; Carreras, Jeanette; Alter, Blanche P; Antin, Joseph H; Ayas, Mouhab; Bodhi, Prasad; ... (31 authors) (Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 2013-08)
      We describe outcomes after allogeneic transplantation in 34 patients with dyskeratosis congenita who underwent transplantation between 1981 and 2009. The median age at transplantation was 13 years (range, 2 to 35). Approximately ...

    • Survival following allogeneic transplant in patients with myelofibrosis. 

      Gowin, Krisstina; Ballen, Karen; Ahn, Kwang Woo; Hu, Zhen-Huan; Ali, Haris; Arcasoy, Murat O; Devlin, Rebecca; ... (68 authors) (Blood advances, 2020-05)
      Allogeneic hematopoietic cell transplantation (HCT) is the only curative therapy for myelofibrosis (MF). In this large multicenter retrospective study, overall survival (OS) in MF patients treated with allogeneic HCT (551 ...

    • Telomeres and the natural lifespan limit in humans. 

      Steenstrup, Troels; Kark, Jeremy D; Verhulst, Simon; Thinggaard, Mikael; Hjelmborg, Jacob VB; Dalgård, Christine; Kyvik, Kirsten Ohm; ... (29 authors) (Aging (Albany NY), 2017-04)
      An ongoing debate in demography has focused on whether the human lifespan has a maximal natural limit. Taking a mechanistic perspective, and knowing that short telomeres are associated with diminished longevity, we examined ...